PSP Research LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0002106939

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q4 2025 · 85 positions · Total reported value $114.42M · Top-10 concentration 65.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 78.9% · 1 new · 27 cut · 32 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.5% · vs SPY -3.6% · Prev Value $187.88M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.5% · vs SPY -2.6% · Latest Value $145.83M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, PSP Research LLC disclosed 85 equity positions with a combined reported value of $114.42M. The filing implies a focused portfolio: its ten largest positions account for 65.8% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q4 2025 were SGOV ($70.27M), PRAX ($584.17K), TVTX ($583.54K). By sector, the heaviest allocations are Health Care 34.4%, Industrials 0.5%.

Versus the prior quarter, PSP Research LLC opened 1 new positions, trimmed 27 and fully exited 32, a turnover rate of 78.9% of positions.

The largest new positions opened in Q4 2025 were SGOV ($70.27M), PRAX ($584.17K), TVTX ($583.54K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • SGOV ISHS 0-3 MTH TREAS BD ETF · $70.27M
  • PRAX PRAXIS PRECISION MEDICINES I · $584.17K
  • TVTX TRAVERE THERAPEUTICS INC · $583.54K
  • TYRA TYRA BIOSCIENCES INCORPORATED · $574.51K
  • PHVS PHARVARIS N V · $569.18K
  • JAZZ JAZZ PHARMACEUTICALS PLC · $553.86K
  • CLDX CELLDEX THERAPEUTICS INC NEW · $553.20K
  • CGON CG ONCOLOGY INC · $551.92K

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest PSP Research LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

PSP Research LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 44 positions worth $145.83M in total. HoldingsHub carries 4 quarters of its filings (Q4 2025–Q3 2026).

Firm Snapshot

  • SEC registration: 801-131402 (status: Approved), registered 2024-11-04
  • Regulatory AUM (Form ADV): $178.64M as of 2026-07-01

Portfolio Structure

  • 44 positions · $145.83M reported value (Q3 2026)
  • Top 10 holdings = 95.0% of reported value
  • Largest position: SGOV (ISHARES TR) at 48.3%
  • Average position size: $3.31M

Sector Tilt

  • Health Care 9.9%
  • (classified holdings cover 10% of value)

Quarterly Activity

  • Q3 2026: 1 new, 27 reduced, 32 exited
  • 16 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 34.4%
Other 65.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 700.00K $70.27M 61.41%
61.41%
New
2 1.98K $584.17K 0.51%
0.51%
New
3 15.27K $583.54K 0.51%
0.51%
New
4 21.85K $574.51K 0.50%
0.50%
New
5 20.51K $569.18K 0.50%
0.50%
New
6 3.26K $553.86K 0.48%
0.48%
New
7 20.37K $553.20K 0.48%
0.48%
New
8 13.29K $551.92K 0.48%
0.48%
New
9 3.44K $550.74K 0.48%
0.48%
New
10 2.58K $549.95K 0.48%
0.48%
New
11 21.87K $549.27K 0.48%
0.48%
New
12 13.56K $547.82K 0.48%
0.48%
New
13 6.87K $547.36K 0.48%
0.48%
New
14 21.88K $547.19K 0.48%
0.48%
New
15 7.14K $546.14K 0.48%
0.48%
New
16 28.71K $544.69K 0.48%
0.48%
New
17 18.72K $543.51K 0.47%
0.47%
New
18 19.42K $542.93K 0.47%
0.47%
New
19 25.25K $542.26K 0.47%
0.47%
New
20 33.95K $541.55K 0.47%
0.47%
New
21 6.85K $541.40K 0.47%
0.47%
New
22 8.03K $540.15K 0.47%
0.47%
New
23 29.53K $539.51K 0.47%
0.47%
New
24 19.28K $539.45K 0.47%
0.47%
New
25 6.80K $537.95K 0.47%
0.47%
New
26 14.82K $537.75K 0.47%
0.47%
New
27 8.22K $536.21K 0.47%
0.47%
New
28 7.05K $535.21K 0.47%
0.47%
New
29 20.31K $534.82K 0.47%
0.47%
New
30 10.76K $534.67K 0.47%
0.47%
New
31 6.12K $534.61K 0.47%
0.47%
New
32 14.28K $534.47K 0.47%
0.47%
New
33 24.62K $534.28K 0.47%
0.47%
New
34 13.83K $534.24K 0.47%
0.47%
New
35 44.22K $534.21K 0.47%
0.47%
New
36 15.48K $534.08K 0.47%
0.47%
New
37 6.52K $533.78K 0.47%
0.47%
New
38 5.08K $532.14K 0.47%
0.47%
New
39 17.51K $531.13K 0.46%
0.46%
New
40 17.81K $530.83K 0.46%
0.46%
New
41 3.05K $530.65K 0.46%
0.46%
New
42 24.40K $530.39K 0.46%
0.46%
New
43 630 $529.80K 0.46%
0.46%
New
44 3.73K $529.59K 0.46%
0.46%
New
45 5.26K $529.20K 0.46%
0.46%
New
46 5.35K $528.42K 0.46%
0.46%
New
47 8.31K $528.21K 0.46%
0.46%
New
48 16.97K $528.01K 0.46%
0.46%
New
49 19.77K $527.95K 0.46%
0.46%
New
50 31.04K $527.68K 0.46%
0.46%
New

FAQ

What did PSP Research LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, PSP Research LLC reported 85 equity positions worth $114.42M in aggregate; its largest disclosed positions were SGOV ($70.27M), PRAX ($584.17K), TVTX ($583.54K).

How large is PSP Research LLC's portfolio?

PSP Research LLC reported $114.42M of long equity holdings across 85 positions as of 2025-Q4. Top-10 holdings account for 65.8% of reported value.

What is PSP Research LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/psp-research/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →